GORDON CARL L

CIK 000128293013 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001282930

Recent Transactions

50 trades

Disposition to Issuer
Keros Therapeutics, Inc.$KROS
Common Stock
2025-11-21$17.75/sh−74,465→ 45,057 total
Disposition to Issuer
Keros Therapeutics, Inc.$KROS
Common Stock
2025-11-21$17.75/sh−140,057→ 759,155 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−230,753→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−323,916→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−74,613→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.60/sh+389,078→ 928,140 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.20/sh+323,916→ 323,916 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.60/sh+230,753→ 1,158,893 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.20/sh+215,146→ 539,062 total
Award
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$4.00/sh+808,894→ 2,042,400 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−389,078→ 0 total
Conversion
Lomond Therapeutics Holdings, Inc.
Simple Agreement for Future Equity
2024-11-01−215,146→ 0 total
Award
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$4.00/sh+155,120→ 2,677,256 total
Award
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$4.00/sh+479,736→ 2,522,136 total
Conversion
Lomond Therapeutics Holdings, Inc.
Common Stock
2024-11-01$3.60/sh+74,613→ 1,233,506 total
Conversion
MBX Biosciences, Inc.$MBX
Series A Convertible Preferred Stock
2024-09-16−12,372,634→ 0 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+250,000→ 653,787 total
Conversion
MBX Biosciences, Inc.$MBX
Series C Convertible Preferred Stock
2024-09-16−4,854,368→ 0 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+403,787→ 403,787 total
Conversion
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16+2,658,428→ 2,658,428 total
Conversion
MBX Biosciences, Inc.$MBX
Series B Convertible Preferred Stock
2024-09-16−19,587,284→ 0 total
Purchase
MBX Biosciences, Inc.$MBX
Common Stock
2024-09-16$16.00/sh+500,000→ 3,158,428 total
Award
MBX Biosciences, Inc.$MBX
Stock Option (Right to Buy)
2024-09-12+15,963→ 15,963 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−18,500→ 0 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+18,500→ 18,500 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−18,500→ 0 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+30,000→ 30,000 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+18,500→ 18,500 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−30,000→ 0 total
Disposition to Issuer
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21−26,400→ 0 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-08-21+26,400→ 26,400 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2024-08-13$44.01/sh−220,600→ 899,212 total
Sale
Keros Therapeutics, Inc.$KROS
Common Stock
2024-08-13$44.01/sh−29,400→ 119,522 total
Sale
Terns Pharmaceuticals, Inc.$TERN
Common Stock
2024-07-16$10.00/sh−4,009→ 4,839,412 total
Sale
Terns Pharmaceuticals, Inc.$TERN
Common Stock
2024-07-16$10.00/sh−623→ 755,635 total
Sale
Terns Pharmaceuticals, Inc.$TERN
Common Stock
2024-07-16$10.00/sh−556→ 1,967,924 total
Sale
Terns Pharmaceuticals, Inc.$TERN
Common Stock
2024-07-15$10.00/sh−39,433→ 4,843,421 total
Sale
Terns Pharmaceuticals, Inc.$TERN
Common Stock
2024-07-15$10.00/sh−5,401→ 1,968,480 total
Sale
Terns Pharmaceuticals, Inc.$TERN
Common Stock
2024-07-15$10.00/sh−6,142→ 756,258 total
Award
Terns Pharmaceuticals, Inc.$TERN
Stock Option (Right to Buy)
2024-07-01+4,676→ 4,676 total
Award
Terns Pharmaceuticals, Inc.$TERN
Stock Option (Right to Buy)
2024-06-10+32,000→ 32,000 total
Award
Adicet Bio, Inc.$ACET
Stock Option (Right to Buy)
2024-06-05+26,400→ 26,400 total
Award
Adicet Bio, Inc.$ACET
Common Stock
2024-06-05+5,900→ 11,800 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-05-30+10,000→ 10,000 total
Exercise of In-Money
BiomX Inc.$PHGE
Common Stock
2024-05-15$0.24/sh+9,280,408→ 13,797,997 total
Sale
BiomX Inc.$PHGE
Common Stock
2024-05-15$0.38/sh−24,344→ 13,773,653 total
Exercise of In-Money
BiomX Inc.$PHGE
Warrants (Right to Buy)
2024-05-15−9,280,408→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Common Stock
2024-04-03−4,738,453→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Common Stock
2024-04-03−1,368,339→ 0 total
Disposition to Issuer
Kinnate Biopharma Inc.
Stock Option (right to buy)
2024-04-03−25,000→ 0 total

Companies

Recent Filings

Address

C/O THESEUS PHARMACEUTICALS, INC. 314 MAIN STREET

CAMBRIDGE, MA, 02142

View on SEC.gov